Both in Pharmaceuticals

IDEAYA Biosciences vs Viking Therapeutics

Over the past year IDYA returned +1.2% and VKTX returned −26.2%; their daily moves had a correlation of 0.41.

IDYA +1.2% VKTX −26.2%Growth of $1, one year, split-adjusted
MetricIDYAVKTX
Price$31.64$26.83
Market cap$3.05B$3.42B
Today−1.00%−1.65%
1 month−15.3%−10.4%
6 months+9.5%−15.5%
Year to date−8.5%−23.7%
1 year+0.1%−29.7%
Revenue growth (YoY)——
Gross margin100.0%—
Net margin−1269.6%—
P/E (TTM)——
Price / sales13.0×—
Net cash$829.0M$709.2M
Dividend yield——
Volatility (60d)37.0%86.6%
Short % of float10.4%22.8%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).